Axsome Therapeutics (AXSM) EBT Growth (3y) (2018 - 2026)
Powered by 
Analysis
Axsome Therapeutics (AXSM) EBT Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 6.22% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.16% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 103.79% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 24.03% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 41.79% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 38.36% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -38.56% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 64.03% |
| 10 | Axsome Therapeutics | 10.75 Bn | 10.43 Bn | 204.81 Mn | 8.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.94% |
| Mar 31, 2026 | -95.50% |
| Dec 31, 2025 | 22.84% |
| Sep 30, 2025 | -1.76% |
| Jun 30, 2025 | -5.70% |
| Mar 31, 2025 | -14.45% |
| Dec 31, 2024 | -30.11% |
| Sep 30, 2024 | -22.80% |
| Jun 30, 2024 | -34.95% |
| Mar 31, 2024 | -32.69% |
| Dec 31, 2023 | -50.18% |
| Sep 30, 2023 | -42.61% |
| Jun 30, 2023 | -54.65% |
| Mar 31, 2023 | 35.69% |
| Dec 31, 2022 | -35.15% |
| Sep 30, 2022 | -32.49% |
| Jun 30, 2022 | -44.40% |
| Mar 31, 2022 | -55.01% |
| Dec 31, 2021 | -78.55% |
| Sep 30, 2021 | -60.01% |